Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
Holding IONS?
Track your performance easily
See the Price Targets and Ratings of:
IONS Analyst Ratings
Moderate Buy
9 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IONS Stock 12 Month Forecast
Average Price Target
$61.92
▲(58.00% Upside)
| Highest Price Target$77.00 | Average Price Target$61.92 | Lowest Price Target$45.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Reiterated
11/07/24
Wells Fargo
Assigned
11/07/24
Stifel Nicolaus
Reiterated
11/07/24
Morgan Stanley
Reiterated
11/07/24
TD Cowen
Reiterated
11/06/24
Needham
Reiterated
11/06/24
Leerink Partners
Assigned
11/06/24
RBC Capital
Reiterated
11/06/24
Guggenheim
Reiterated
10/09/24
Laidlaw
Reiterated
10/08/24
Bank of America Securities
$68
Buy
73.51%
Upside
Reiterated
09/25/24
Ionis Pharmaceuticals: A Strong Buy on Promising Pipeline and Strategic Financial Health
Jefferies
$77
Buy
96.48%
Upside
Assigned
09/11/24
Analysts Offer Insights on Healthcare Companies: AN2 Therapeutics, Inc. (NASDAQ: ANTX), MoonLake Immunotherapeutics (NASDAQ: MLTX) and Ionis Pharmaceuticals (NASDAQ: IONS)
J.P. Morgan
$50→$55
Hold
40.34%
Upside
Reiterated
08/26/24
Ionis Pharmaceuticals (IONS) PT Raised to $55 at JPMorganJPMorgan analyst Jessica Fye raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $50.00) while maintaining a Neutral rating.
Oppenheimer
$75
Buy
91.38%
Upside
Reiterated
08/02/24
Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Cigna (CI)
Goldman Sachs
$33→$37
Sell
-5.59%
Downside
Reiterated
08/02/24
Ionis Pharmaceuticals (IONS) PT Raised to $37 at Goldman SachsGoldman Sachs analyst Salveen Richter raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $37.00 (from $33.00) while maintaining a Sell rating.
Best Analysts Covering Ionis Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy IONS and Sell After:
1 Month
xxx
Success Rate
13/27 ratings generated profit
Average Return
+1.87%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 48.15% of your transactions generating a profit, with an average return of +1.87% per trade.
3 Months
xxx
Success Rate
16/27 ratings generated profit
Average Return
+2.37%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.26% of your transactions generating a profit, with an average return of +2.37% per trade.
1 Year
Success Rate
17/27 ratings generated profit
Average Return
+7.94%
reiterated a buy rating 4 months ago
Copying David Lebowitz's trades and holding each position for 1 Year would result in 62.96% of your transactions generating a profit, with an average return of +7.94% per trade.
2 Years
xxx
Success Rate
16/27 ratings generated profit
Average Return
+4.90%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 59.26% of your transactions generating a profit, with an average return of +4.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IONS Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
19
7
8
8
10
Buy
11
14
12
7
2
Hold
13
12
8
6
4
Sell
1
1
1
1
0
Strong Sell
0
0
0
0
0
total
44
34
29
22
16
Each month's total comprises the sum of three months' worth of ratings.
IONS Financial Forecast
IONS Stock Forecast FAQ
What is IONS’s average 12-month price target, according to analysts?
Based on analyst ratings, Ionis Pharmaceuticals’s 12-month average price target is $61.92.
What is IONS’s upside potential, based on the analysts’ average price target?
Ionis Pharmaceuticals has 58.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IONS a Buy, Sell or Hold?
Ionis Pharmaceuticals has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.
What is Ionis Pharmaceuticals’s price target?
The average price target for Ionis Pharmaceuticals is $61.92. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $77.00 ,the lowest forecast is $45.00. The average price target represents 58.00% Increase from the current price of $39.19.
The highest analyst price target is $77.00 ,the lowest forecast is $45.00. The average price target represents 58.00% Increase from the current price of $39.19.
What do analysts say about Ionis Pharmaceuticals?
Ionis Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of IONS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.